10m Placement @ 20c, page-41

Yeah, we the speculators have pushed the stock from under $20m cap to now around $150m cap. Any significant gains from here will necessarily require institutional money to flow in.

I guess htis placement should serve 2 purposes: to accelerate RAP's business (FDA, trials, marketing etc), and to satisfy institutional demand for stock so as to sow the seeds on the capital market for the next stage.
RAP was the most popular with audiences during recent Techknow show right?

Short term a little peeved but on reflection this is perhaps very necessary and we should be happy. Zero stock price got the huge kick up after their huge CR (around $18 I remember).

For RAP and RAP existing shareholders, $10m is better than $5m. The more the better.